Catalogo dei prodotti della ricerca

SCIARRA, Alessandro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.671
EU - Europa 7.414
AS - Asia 5.247
SA - Sud America 449
AF - Africa 213
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 10
Totale 29.035
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.483
IT - Italia 3.665
SG - Singapore 2.478
CN - Cina 1.331
IN - India 1.106
UA - Ucraina 702
FI - Finlandia 679
SE - Svezia 603
RU - Federazione Russa 555
DE - Germania 409
BR - Brasile 312
GB - Regno Unito 173
CA - Canada 153
TG - Togo 145
NL - Olanda 103
IE - Irlanda 98
AR - Argentina 92
ID - Indonesia 92
BG - Bulgaria 80
BE - Belgio 71
FR - Francia 66
TR - Turchia 43
AT - Austria 41
CH - Svizzera 33
MX - Messico 30
RO - Romania 27
IR - Iran 24
AU - Australia 22
PL - Polonia 20
ZA - Sudafrica 19
CL - Cile 18
KR - Corea 17
HK - Hong Kong 16
LT - Lituania 15
EG - Egitto 14
ES - Italia 14
JP - Giappone 14
IQ - Iraq 13
PH - Filippine 13
IL - Israele 11
MK - Macedonia 11
BD - Bangladesh 10
EU - Europa 10
PK - Pakistan 10
CO - Colombia 9
NZ - Nuova Zelanda 9
UZ - Uzbekistan 9
JO - Giordania 7
MA - Marocco 7
NO - Norvegia 7
PT - Portogallo 6
TH - Thailandia 6
TW - Taiwan 6
VE - Venezuela 6
VN - Vietnam 6
EC - Ecuador 5
GR - Grecia 5
KE - Kenya 5
KG - Kirghizistan 5
RS - Serbia 5
SC - Seychelles 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
DZ - Algeria 4
LU - Lussemburgo 4
LV - Lettonia 4
SY - Repubblica araba siriana 4
AL - Albania 3
CZ - Repubblica Ceca 3
HR - Croazia 3
ML - Mali 3
MY - Malesia 3
NG - Nigeria 3
PA - Panama 3
SA - Arabia Saudita 3
AM - Armenia 2
BO - Bolivia 2
EE - Estonia 2
GE - Georgia 2
OM - Oman 2
PE - Perù 2
SN - Senegal 2
TN - Tunisia 2
UY - Uruguay 2
AD - Andorra 1
BF - Burkina Faso 1
BH - Bahrain 1
BZ - Belize 1
CI - Costa d'Avorio 1
CM - Camerun 1
DK - Danimarca 1
HU - Ungheria 1
JM - Giamaica 1
KH - Cambogia 1
LB - Libano 1
MD - Moldavia 1
MT - Malta 1
MU - Mauritius 1
NP - Nepal 1
PS - Palestinian Territory 1
Totale 29.031
Salva come PNG Salva come JPEG
Città #
Fairfield 2.146
Chandler 1.312
Singapore 1.223
Woodbridge 1.107
Ashburn 958
Rome 836
Princeton 770
Seattle 768
Houston 756
Wilmington 707
Cambridge 648
Ann Arbor 533
Plano 514
Beijing 405
Santa Clara 397
Millbury 389
San Paolo di Civitate 306
Jacksonville 266
Cosenza 224
Lawrence 214
San Diego 203
Helsinki 166
Andover 157
Boston 147
Lomé 145
Milan 141
Moscow 140
Hefei 137
Des Moines 129
Nanjing 114
Norwalk 113
Toronto 110
Dearborn 109
Kunming 102
Falkenstein 100
San Mateo 94
Dublin 90
Jakarta 90
Boardman 89
Federal 80
Sofia 76
New York 75
Falls Church 70
Nanchang 63
Jinan 61
Brussels 60
Munich 58
Guangzhou 57
Yubileyny 50
Bühl 43
Naples 40
London 37
Mannheim 34
Ankara 30
Fuzhou 30
Nuremberg 28
São Paulo 28
Amsterdam 27
Florence 27
Ottawa 27
Chengdu 26
Dallas 26
Grafing 23
Los Angeles 23
Vienna 22
Bologna 20
Frankfurt am Main 20
Bari 19
Napoli 19
Shenyang 18
Baotou 17
Fremont 17
Southend 17
Council Bluffs 16
Latina 16
Palermo 16
Torino 16
Zhengzhou 16
San Jose 15
Warsaw 15
Wuhan 15
Auburn Hills 14
Bern 14
Phoenix 14
Redmond 14
Hong Kong 13
Mexico City 13
Ningbo 13
Shaoxing 13
Chongqing 12
Genova 12
Lappeenranta 12
Turin 12
Verona 12
Brescia 11
Buffalo 11
Cairo 11
Catania 11
Changsha 11
Genoa 11
Totale 18.482
Salva come PNG Salva come JPEG
Nome #
RUOLO DELLA CISTOGRAFIA - TC CON CISTOSCOPIA VIRTUALE MEDIANTE APPARECCHIATURA MULTISTRATO NELLA IDENTIFICAZIONE DELLE NEOPLASIE VESCICALI 904
Raro caso di tumore adenomatoide multiplo ad origine dalla tunica vaginale del testicolo e dell’epididimo. 686
Prostate Cancer Unit Policlinico Umbertyo I- Universita' Sapienza Roma 283
Psychological and functional effect of different primary treatments for prostate cancer: a comparative prospective analysis 150
Immunotherapy in prostate cancer. Recent advances and future directions 143
2D and 3D T2-weighted MR sequences for the assessment of neurovascular bundle changes after nerve-sparing radical retropubic prostatectomy with erectile function correlation 142
Can the intraprostatic concentration of epidermal growth factor influence the variance of serum prostate specific antigen levels in patients with benign prostatic hyperplasia? 127
Independent value of tumor size and DNA ploidy for the prediction of disease progression in patients with organ-confined renal cell carcinoma 124
Antiandrogen monotherapy: Recommendations for the treatment of prostate cancer 123
A chemosensitivity test to individualize intravesical treatment for non-muscle-invasive bladder cancer 119
Modern role of magnetic resonance and spectroscopy in the imaging of prostate cancer 118
Prostate imaging reporting and data system 3 category cases at multiparametric magnetic resonance for prostate cancer. A systematic review and meta-analysis 109
Neoadjuvant therapy with sorafenib in advanced renal cell carcinoma with vena cava extension submitted to radical nephrectomy 107
Negative multiparametric magnetic resonance imaging for prostate cancer: what's next? 106
A perspective of immunotherapy for prostate cancer 105
Characterization of circulating blood dendritic cell subsets DC123+ (lymphoid) and DC11C+ (myeloid) in prostate adenocarcinoma patients 103
Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: A retrospective analysis 101
COMPLETE RESPONSE TO THE COMBINATION THERAPY WITH ANDROGEN BLOCKADE AND SOMATOSTATIN ANALOGUE IN A PATIENT WITH ADVANCED PROSTATE CANCER: MAGNETIC RESONANCE IMAGING WITH 1H-SPECTROSCOPY: Part 2 101
Advances in Magnetic Resonance Imaging: How They Are Changing the Management of Prostate Cancer 100
Increased PSA expression on prostate cancer exosomes in in vitro condition and in cancer patients 100
Mineral metabolism abnormalities in patients with prostate cancer: a systematic case controlled study 100
Chromogranin A expression in familial versus sporadic prostate cancer 99
MRI-targeted or standard biopsy for prostate-cancer diagnosis 99
Quality of life after prostate cancer diagnosis: data from the pros-IT CNR 98
Beyond the immune suppression: the immunotherapy in prostate cancer 97
MRI/US fusion-guided biopsy: performing exclusively targeted biopsies for the early detection of prostate cancer 97
Editorial Comment on: Shifting the Paradigm of Testosterone and Prostate Cancer: The Saturation Model and the Limits of Androgen-Dependent Growth 96
null 96
Psychological impact of different primary treatments for prostate cancer. a critical analysis 95
A meta-analysis and systematic review of randomized controlled trials with degarelix versus gonadotropin-releasing hormone agonists for advanced prostate cancer 95
Apalutamide for metastatic, castration-sensitive prostate cancer 94
Variation in chromogranin A serum levels during intermittent versus continuous androgen deprivation therapy for prostate adenocarcinoma 93
New anti-angiogenic targeted therapy in advanced renal cell carcinoma (RCC): Current status and future prospects 93
Bladder carcinoma: MDCT cystography and virtual cystoscopy 92
Prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging 92
Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer 92
Untargeted metabolomics of prostate cancer zwitterionic and positively charged compounds in urine 92
Histopathological aspects of transitional cell carcinoma of the bladder: Analysis of 20 years experience 91
Functional Magnetic Resonance Imaging in Prostate Cancer 90
MRI-directed biopsy for primary detection of prostate cancer in a population of 223 men: MRI In-Bore vs MRI-transrectal ultrasound fusion-targeted techniques 90
"2D AND 3D T2-WEIGHTED MAGNETIC RESONANCE (MR) SEQUENCES FOR THE ASSESSMENT OF NEUROVASCULAR BUNDLES CHANGES AFTER NERVE-SPARING RADICAL RETROPUBIC PROSTATECTOMY: CORRELATION WITH ERECTILE FUNCTION" 90
Androgen receptor variant 7 (AR-V7) in sequencing therapeutic agents for castratrion resistant prostate cancer: A critical review 89
In vivo 3D neuroanatomical evaluation of periprostatic nerve plexus with 3T-MR Diffusion Tensor Imaging 89
Early recovery of urinary continence after radical prostatectomy using early pelvic floor electric stimulation and biofeedback associated treatment 88
Use of Multiparametric MR with Neurovascular Bundle Evaluation to Optimize the Oncological and Functional Management of Patients Considered for Nerve-Sparing Radical Prostatectomy 88
Laparoscopic versus open radical prostatectomy in high prostate volume cases: impact on oncological and functional results 88
Androgen-deprivation therapy and SARS-Cov-2 infection: the potential double-face role of testosterone 88
Comparative analysis of multiparametric magnetic resonance and PET-CT in the management of local recurrence after radical prostatectomy for prostate cancer 87
A systematic review and meta-analysis of clinical trials implementing aromatase inhibitors to treat male infertility 86
The impact of radical prostatectomy on global climate: a prospective multicentre study comparing laparoscopic versus robotic surgery 85
Correlation between magnetic resonance imaging with 1H-spectroscopy, PSA levels and gleason score in the diagnosis of locally recurrent prostate cancer 85
Adjuvant therapy with sorafenib in bone Metastases bilateral renal carcinoma: a case report: Part II 84
Prognostic value of inflammation in prostate cancer progression and response to therapeutic: A critical review 84
Anatomia chirurgica della Prostata: cosa deve "vedere" l'imaging. 83
Prostate cancer unit for an optimal management of prostate cancer unit. ["Prostate cancer unit" per un management ottimale dei pazienti con tumore prostatico] 83
Editorial Comment on: MR-Guided Biopsy of the Prostate: An Overview of Techniques and a Systematic Review 82
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study) 82
EVIDENCE THAT SERENOA-REPENS EXTRACT DISPLAYS AN ANTIESTROGENIC ACTIVITY IN PROSTATIC TISSUE OF BENIGN PROSTATIC HYPERTROPHY PATIENTS 82
EARLY RECOVERY OF URINARY CONTINENCE AFTER RADICAL PROSTATECTOMY USING EARLY PELVIC FLOOR ELECTRIC STIMULATION AND BIOFEEDBACK ASSOCIATED TREATMENT 81
Etoricoxib and intermittent androgen deprivation (IAD) therapy in patients with biochemical progression after radical prostatectomy 81
Lower urinary tract symptoms (LUTS) and sexual dysfunction (SD): New targets for new combination therapies? 80
Estrogens and aspects of prostate disease 80
Biomarkers in prostate cancer diagnosis: from current knowledge to the role of metabolomics and exosomes 80
Value of magnetic resonance spectroscopy (MSR) and dynamic contrast-enhanced magnetic resonance (DCEMR) imaging for the characterization of high-grade prostatic intraepithelial neoplasia (HGPIN) foci 80
Network analysis integrating microRNA expression profiling with MRI biomarkers and clinical data for prostate cancer early detection: a proof of concept study 80
DNA ploidy, Gleason score, pathological stage and serum PSA levels as predictors of disease-free survival in C-D1 prostatic cancer patients submitted to radical retropubic prostatectomy 79
Prostate-specific antigen increase during dutasteride to indicate the need for prostate biopsy: influence of prostatic inflammation 79
Loss of Renal Function After Retrograde Ureteral Placement of an Allium Stent for Severe Ureteral Stricture 79
Predictors of hospitalization after ureteroscopy plus elective double-j stent as an outpatient procedure 79
The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH) 78
Adding systematic biopsy to magnetic resonance ultrasound fusion targeted biopsy of the prostate in men with previous negative biopsy or enrolled in active surveillance programs 78
Use of multiparametric MR with neurovascular bundle evaluation to optimize the oncological and functional management of patients considered for nerve sparing radical prostatectomy 78
Cribriform pattern does not have a significant impact in Gleason Score ≥7/ISUP Grade ≥2 prostate cancers submitted to radical prostatectomy 78
Early Recovery of Urinary Continence After Radical Prostatectomy Using Early Pelvic Floor Electrical Stimulation and Biofeedback Associated Treatment 78
Prognostic predictors in prostate cancer cases with biochemical progression after surgery treated with intermittent androgen deprivation (IAD) 77
Value of magnetic resonance spectroscopy imaging and dynamic contrast-enhanced imaging for detecting prostate cancer foci in men with prior negative biopsy 76
USE OF MULTIPARAMETRIC MR WITH NEUROVASCULAR BUNDLE EVALUATION TO OPTIMIZE THE ONCOLOGICAL AND FUNCTIONAL MANAGEMENT OF PATIENTS CONSIDERED FOR NERVE SPARING RADICAL PROSTATECTOMY 76
A Novel Therapeutic Option for Castration-resistant Prostate Cancer: After or Before Chemotherapy? 76
Pros-IT CNR: an Italian prostate cancer monitoring project 76
Benign prostatic hyperplasia: What about a campaign for prevention? 75
Combination therapy with rofecoxib and finasteride in the treatment of men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH) 75
Biopsy-derived gleason artifact and prostate volume: Experience using ten samples in larger prostates 75
Adjuvant therapy with sorafenib in bone metastases bilateral renal carcinoma: a case report. 75
Prospective validation study of a novel integrated pathway based on clinical features, MRI biomarkers and microRNAs for early detection of prostate cancer 74
Chromogranin A and biochemical progression free survival in prostate adenocarcinomas submitted to radical prostatectomy 74
Complete response to the combination therapy with androgen blockade and somatostatin analogue in a patient with advanced prostate cancer: Magnetic resonance imaging with 1H-spectroscopy 74
Interobserver reproducibility of the PRECISE scoring system for prostate MRI on active surveillance: results from a two-centre pilot study 74
The emerging landscape of tumor marker panels for the identification of aggressive prostate cancer: the perspective through bibliometric analysis of an Italian translational working group in uro-oncology 74
Effect of Serenoa repens (Permixon®) on the expression of inflammation-related genes: Analysis in primary cell cultures of human prostate carcinoma 74
Impact of uni- or multifocal perineural invasion in prostate cancer at radical prostatectomy 73
Modeling the contribution of male testosterone levels to the duration of positive COVID testing among hospitalized male COVID-19 patients 73
Clinical evidence of neuroendocrine differentiation in a patient with prostate cancer and bone marrow micrometastases 72
Chromogranin A and biochemical progression-free survival in prostate adenocarcinomas submitted to radical prostatectomy 72
Human Papilloma Virus DNA Detection, p53 and Ki67 Expression in Penile Verrucous and Squamous Cell Carcinomas in the Same Patient 72
Effect of nonsteroidal antiandrogen monotherapy versus castration therapy on neuroendocrine differentiation in prostate carcinoma 71
Gleason score ≥ 8 prostate adenocarcinoma is associated with higher serum chromogranin A levels also in non metastatic disease. 71
Neuroendocrine differentiation in human prostate tissue: Is it detectable and treatable? 71
Prostate Cancer Gene 3 and Multiparametric Magnetic Resonance Can Reduce Unnecessary Biopsies: Decision Curve Analysis to Evaluate Predictive Models 71
Intermittent androgen deprivation in prostate cancer cases with biochemical progression after radical prostatectomy: Are we ready to treat? 71
Magnetic resonance spectroscopic imaging (1H-MRSI) and dynamic contrast-enhanced magnetic resonance (DCE-MRI): Pattern changes from inflammation to prostate cancer 71
Totale 10.466
Salva come PNG Salva come JPEG
Categoria #
all - tutte 105.151
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.151
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.197 0 0 0 0 0 0 0 0 457 347 244 149
2020/20212.332 204 262 132 300 105 95 64 261 167 281 390 71
2021/20225.474 79 331 492 147 746 170 115 502 448 502 771 1.171
2022/20235.090 1.327 914 202 492 499 512 117 288 420 49 176 94
2023/20242.597 203 344 95 186 189 247 127 196 26 374 249 361
2024/20255.217 307 311 423 371 600 507 671 501 1.526 0 0 0
Totale 30.017